TrialJournal of Korean medical science2023

Sex-Based Outcomes of P2Y12 Inhibitor Monotherapy After Three Months of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention.

Eun-Seok Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.